Navigation Links
Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Date:3/17/2011

ded period of time continued to show undetectable virus levels six months after they completed SOC. SOC treatment alone usually results in about 40-50% of patients reaching undetectable virus levels after six months of treatment.

About Inovio Pharmaceuticals, Inc. Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include three separate programs in Phase II clinical studies, including VGX-3100 for treating cervical dysplasia and cancer. Other Inovio clinical programs include those for avian flu (preventive) and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may n
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
2. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
3. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
6. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
7. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
8. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
9. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
10. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
11. Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014 Biomerics ... the medical device market, announced its merger with ... Advanced Catheter Division. The new division was formed to ... device solutions for the structure heart, interventional radiology, ... Biomerics Advanced Catheter will be led by ...
(Date:9/15/2014)... , Sept. 15, 2014  Decision Resources Group ... continues to expand, increasing pressure to control expenditures will ... payers emphasize that although type 2 diabetes drugs will ... are likely to enforce additional restrictions on expensive agents. ... , Germany , ...
(Date:9/15/2014)... SALT LAKE CITY , Sept. 15, 2014 ... innovative minimally invasive surgical (MIS) visualization products, is ... 13485:2003 certification for its quality management system (QMS) ... is another important step in Olive Medical complying ... of medical devices.  It is the goal of ...
Breaking Medicine Technology:Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 2Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 3Olive Medical Achieves ISO 13485:2003 Certification 2
... , , ST LOUIS, Dec. 8 Veran ... the U.S. Food and Drug Administration (FDA) to market a ... "Veran is excited about this clearance as it allows ... lung cancer diagnosis and treatment," said Jerome R. Edwards, Veran ...
... Calif., Dec. 8 Southern California-based philanthropy Free Wheelchair Mission ... the first time ever, as according to the November 30, ... was noted for its strong revenue among a list of ... economic difficulty. , "We are pleased to be ...
Cached Medicine Technology:Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2
(Date:9/15/2014)... Transvaginal mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) ... in the federal multidistrict litigation now underway in U.S. ... LLP reports. According to documents filed in the proceeding, ... that provides for the severance of several actions in ... affected plaintiffs has objected to severance of the cases. ...
(Date:9/15/2014)... to recent studies, approximately one out of every 40 individuals ... responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that ... University of Missouri have made a recent breakthrough with the ... in animal models of the disease. In April, a patent ... "The strategy our lab is using to fight SMA is ...
(Date:9/15/2014)... Alto, CA (PRWEB) September 15, 2014 ... anniversary since its founding in 2007. To mark the ... local community for supporting the village and helping it ... provides a safe, secure and fun community for seniors. ... to the community and live in their own homes. ...
(Date:9/15/2014)... (HealthDay News) -- Births of multiple babies cost more ... singleton births, researchers report. The researchers suggest that ... (IVF) could ease some of that burden. Over ... tandem with births to older mothers and use of ... of New South Wales, Australia. Their study, published ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Providing ... Cherry Bekaert LLP (“the Firm”) is ... as a Director with the Firm’s Litigation ... 25 years of experience, Wolf will assist clients ... advisory and transactional advisory matters. He will also ...
Breaking Medicine News(10 mins):Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 2Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 3
... deadly, say authors of a new survey , , TUESDAY, May ... level of driving experience, putting them at risk for accidents ... many teens recognize that drinking and driving don,t mix, many ... having friends in the car. , "We listened to teenagers ...
... Provided for Successfully Tackling This Valuable ... Part of Her ... on their,plates -- from carpool queen to coach, counselor to chef. It,s ... childhood,obesity and inadequate nutrition, many moms have taken on yet another,important role ...
... announced financial,and operating results for its first quarter ended March 31, ... percent to $7.127 billion. -- Net income totaled $170 million, ... year,s first quarter. -- Adjusted EBITDA totaled $1.180 billion, compared ... of 2007. -- Provision for doubtful accounts increased to $888 ...
... 6 , - International Reach of ,Young ... For the first time, a researcher from ... (APA) prestigious "Young Minds in,Psychiatry" awards, which were ... Washington, DC. The awards, supported by an educational ...
... Hope, fundraising efforts honor Marcus,s dog Tasha and her ... life-threatening blood disorder, DENVER, May 6 Racing driver ... 2008 season race proceeds from their new,BMW Z4 M Coupe ... (MAF). All donations to Meisha,s Hope are used to fund ...
... Market Research Reveals, CHICAGO, May 6 ... in the new three-dimensional research study --,Understanding Gluten ... international findings deliver an innovative 360 degree view,of ... qualitative,insights from customers living with food allergies, celiac ...
Cached Medicine News:Health News:Many Teen Drivers Don't Think They're Inexperienced 2Health News:Many Teen Drivers Don't Think They're Inexperienced 3Health News:Got Milk? Campaign Will Recognize and Reward Moms for Their Role as the Family's Chief Health Officer 2Health News:Got Milk? Campaign Will Recognize and Reward Moms for Their Role as the Family's Chief Health Officer 3Health News:HCA Reports First Quarter 2008 Results 2Health News:HCA Reports First Quarter 2008 Results 3Health News:HCA Reports First Quarter 2008 Results 4Health News:HCA Reports First Quarter 2008 Results 5Health News:HCA Reports First Quarter 2008 Results 6Health News:HCA Reports First Quarter 2008 Results 7Health News:HCA Reports First Quarter 2008 Results 8Health News:HCA Reports First Quarter 2008 Results 9Health News:HCA Reports First Quarter 2008 Results 10Health News:HCA Reports First Quarter 2008 Results 11Health News:HCA Reports First Quarter 2008 Results 12Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 2Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 3Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 4Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 5Health News:Racing Professional Steve Marcus Pledges Season BMW Proceeds to Morris Animal Foundation's Meisha's Hope Fund 2Health News:80% of Customers Eat Out Less Due to Food Allergies and Celiac / Coeliac Disease Impacting Quality of Life 2
Table mount stabilizer system...
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy....
... long-pulsed Nd:YAG laser system with a wavelength of ... deep-lying, superficial as well as red and blue ... in patients with darker skin types (1 to ... for general improvement of skin texture. The handpieces ...
... SINON is a Q-switched ruby ... of 694 nm. High Performance ... - This combination of high ... in Q-switched mode effectively destroys ...
Medicine Products: